Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, cash reserves at Silexion Therapeutics Corp fell by 110.95m. However, the company earned 306.38k from its operations for a Cash Flow Margin of --. In addition the company used on investing activities and also paid 111.25m in financing cash flows.
Cash flow per share | -0.0572 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.6559 |
---|---|
Tangible book value per share | 0.6559 |
More ▼
Balance sheet in USDView more
Current ratio | 1.74 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼